OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

OrganiGram Holdings Inc.TSX: OGI.TO

Accounts Payables · Q2 FY2026 · quarter ended Mar 2026

Accounts payables outflow grows to CA$0

Q2 FY2026 accounts payables was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month accounts payables was CA$0.

Context

  • Accounts payables amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Accounts payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearSep 2025
CA$0— YoY
LTMMar 2026
CA$0— YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

CAD · from the cash flow

Latest · FY2025
0 CAD
Year-over-year change
—

Accounts Payables vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Accounts payables amounts to 0.0% of revenue for OGI.TO, versus a peer median of 1.8%.
OGI.TO Competitors
Accounts Payables for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$8.04M CAD-159.1%-0.1%2.5%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$6.02M CAD-234.6%—3.8%
DR.TOMedical Facilities CorporationLTM Mar 2026$4.49M USD+349.5%-8.9%1.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$4.35M CAD-71.9%—1.4%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$3.31M USD+279.8%+22.0%—
TSND.TOTerrAscend Corp.LTM Mar 2026$3.14M USD-22.4%-33.7%1.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$1.24M USD+255.2%—2.4%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$973.33K USD+1180.7%-4.7%1.9%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$925.95K USD+123.4%-35.8%1.7%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding OGI.TO) —+123.4%-6.8%1.8%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
Deferred Income Tax42.21M(88K)(3.62M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(5.52M)27.02M13.16M
Other Non-Cash Items776K(29M)155.33M15.09M12.47M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(7.59M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(17.05M)
Acquisitions (Net)(2.54M)(11.06M)1.03M257K(65.62M)
Purchases of Investments(120.02M)(15M)(10M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M49.4M3.52M2.5M
Other Investing Activities(31.08M)4.29M(8.65M)(7.97M)(1.52M)
Investing Cash Flow(115.11M)44.03M1.36M(38.77M)(82.67M)
Debt Repayment(116.4M)(1.01M)(87K)(786K)(60K)
Common Stock Issued284.88M6.34M20K108.56M41.18M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(750K)6K(1.79M)
Financing Cash Flow174.46M5.33M(817K)107.78M39.33M
Effect of Forex Changes0000313K
Net Change in Cash30.77M13.15M(34.65M)72.88M(49.01M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(24.64M)

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.